Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer CEO leaves 'extremely demanding' job

jeff_kindler.gi.top.jpgJeff Kindler retires from his position as CEO of Pfizer. By Catherine Clifford, staff reporter


NEW YORK (CNNMoney.com) -- Pfizer said CEO Jeffrey Kindler has retired from the job because it had been "extremely demanding" on him personally.

The drug maker named the head of its global biopharmaceutical operations, Ian Read, as Kindler's successor.

"The combination of meeting the requirements of our many stakeholders around the world and the 24/7 nature of my responsibilities has made this period extremely demanding on me personally," said Kindler in a prepared statement released late Sunday. "I am excited at the opportunity to recharge my batteries, spend some rare time with my family, and prepare for the next challenge in my career."

Kindler had been at Pfizer for 9 years and CEO for four and a half of those years.

During Kindler's time at the helm, Pfizer acquired Wyeth, completing the transaction on Oct. 15, 2009. Since then, the work force has been reduced by 6,900 workers.

As of May, the total work force was approximately 113,800, down from 138,000 people that were employed by both companies in 2008. The company plans to reduce the total to 107,800 in five years.

Pfizer shares eased 0.6% in premarket trading. To top of page

Search for Jobs

Index Last Change % Change
Dow 19,804.72 -22.05 -0.11%
Nasdaq 5,555.66 16.93 0.31%
S&P 500 2,271.89 4.00 0.18%
Treasuries 2.39 0.06 2.66%
Data as of 6:31am ET
Company Price Change % Change
Bank of America Corp... 22.63 0.58 2.63%
Ford Motor Co 12.41 0.00 0.00%
Chesapeake Energy Co... 6.98 -0.03 -0.43%
Citigroup Inc 57.39 -0.99 -1.70%
Reynolds American In... 58.00 0.32 0.55%
Data as of Jan 18
Sponsors

Sections

Irish drug maker Mallinckrodt will have to pay a $100 million fine and allow one of its competitors to produce a life-saving medication used to treat infants. The company hiked the price of the drug from $40 per vial to more than $34,000 per vial over the course of about 15 years. More

Federal Reserve Chair Janet Yellen gave her outlook on monetary policy days before Donald Trump becomes president. More

Nintendo's debut smartphone game Super Mario Run is coming to the Android app store in March, months after it launched on Apple devices. More

Navient, formerly part of Sallie Mae, was sued by the CFPB Wednesday for allegedly cheating borrowers out of repayment rights. More